These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6315636)

  • 1. Absence of decremental response in decentralized muscles of a myasthenic patient.
    Fiacchino F; Crenna P; Sghirlanzoni A; Peluchetti D; Allegranza A
    Ital J Neurol Sci; 1983 Sep; 4(3):355-7. PubMed ID: 6315636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.
    Fambrough DM; Drachman DB; Satyamurti S
    Science; 1973 Oct; 182(4109):293-5. PubMed ID: 4742736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders of neuromuscular transmission].
    Kwieciński H
    Neurol Neurochir Pol; 1998; 32 Suppl 1():13-21. PubMed ID: 9608549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper motor neuron dysfunction reduces the EMG evidence of myasthenia gravis.
    Fiacchino F; Scaioli V; Antozzi C; Giannini A
    J Neurosurg Anesthesiol; 1995 Jul; 7(3):178-82. PubMed ID: 7549369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis.
    Wang X; Rich MM
    Ann N Y Acad Sci; 2018 Jan; 1412(1):170-177. PubMed ID: 28981978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of myasthenia explained.
    Verschuuren JJ; Palace J; Gilhus NE
    Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neuromuscular transmission disorder: combined myasthenia gravis and Lambert Eaton syndrome in one patient.
    Taphoorn MJ; Van Duijn H; Wolters EC
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):880-2. PubMed ID: 2841430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles.
    Serra A; Ruff R; Kaminski H; Leigh RJ
    Ann N Y Acad Sci; 2011 Sep; 1233():26-33. PubMed ID: 21950972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurophysiological testing in myasthenia syndromes].
    Kostera-Pruszczyk A; Rowińska-Marcińska K; Emeryk-Szajewska B
    Neurol Neurochir Pol; 2003; 37(1):161-72. PubMed ID: 12910838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology of myasthenia gravis and the myasthenic syndrome].
    Struppler A; Ruprecht EO
    Anaesthesist; 1971 Jan; 20(1):29-35. PubMed ID: 4322997
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles.
    Serra A; Ruff RL; Leigh RJ
    Ann N Y Acad Sci; 2012 Dec; 1275(1):129-35. PubMed ID: 23278588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evoked responses in normal and diseased muscle with particular reference to twitch potentiation.
    Krarup C
    Acta Neurol Scand; 1983 Nov; 68(5):269-315. PubMed ID: 6320576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic aspects of myasthenia gravis].
    Friedli WG
    Schweiz Rundsch Med Prax; 1989 Sep; 78(38):1037-44. PubMed ID: 2552554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Munc18-1 in synaptic plasticity at the myasthenic neuromuscular junction.
    Sons MS; Verhage M; Plomp JJ
    Ann N Y Acad Sci; 2003 Sep; 998():404-6. PubMed ID: 14592907
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 20. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M; Sakato S; Okumura S
    J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.